Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Pharmaceuticals & Biotech
Create a narrative
Novartis Community
SWX:NOVN Community
1
Narratives
written by author
0
Comments
on narratives written by author
97
Fair Values set
on narratives written by author
Create a narrative
Novartis
Popular
Undervalued
Overvalued
Community Investing Ideas
Novartis
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Pluvicto And Leqvio Expansion Will Sustain Performance Amid Patent Challenges
Key Takeaways Novartis shows strong growth in key brands and anticipates continued pipeline success, potentially boosting future sales and earnings. Expanding innovative therapies and operational efficiencies are expected to offset patent expirations and support net margin expansion.
View narrative
CHF 95.83
FV
5.4% undervalued
intrinsic discount
2.34%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
75
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
NOVN
NOVN
Novartis
Your Fair Value
CHF
Current Price
CHF 90.63
9.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
59b
2015
2018
2021
2024
2025
2027
2030
Revenue US$58.6b
Earnings US$13.5b
Advanced
Set Fair Value